Questionnaire survey of application in S7A Safety Pharmacology Guideline (Part 1) : Point of experimental items (STATISTICAL METHODS) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)
スポンサーリンク
概要
- 論文の詳細を見る
- 日本トキシコロジー学会の論文
- 2003-10-31
著者
-
SAITO Mamoru
Japan Pharmaceutical Manufacturers Association (JPMA) QT PRODACT
-
Ando Kentaro
Non-clinical Evaluation Subcommittee Drug Evaluation Japan Pharmaceutical Manufacturers Association
-
Ando Kentaro
Japan Agency Of Marine-earth Science And Technology
-
Saito Mamoru
Drug Safety Research Laboratories Eisai Co. Ltd.
-
Ichitsubo Tatsuya
Japan Pharmaceutical Manufacturers Association
-
FUKUDA HITOSHI
Japan Pharmaceutical Manufacturers Association
-
URANO YOSUKE
Japan Pharmaceutical Manufacturers Association
-
OKAYACHI HIROSHI
Japan Pharmaceutical Manufacturers Association
-
OGAWA CHISATO
Japan Pharmaceutical Manufacturers Association
-
OKUMURA MAKOTO
Japan Pharmaceutical Manufacturers Association
-
KASAHARA KENICHI
Japan Pharmaceutical Manufacturers Association
-
KUBOTA KUNITSUGU
Japan Pharmaceutical Manufacturers Association
-
KUME ETSUKO
Japan Pharmaceutical Manufacturers Association
-
KONDA TOMOYUKI
Japan Pharmaceutical Manufacturers Association
-
SHIMIZU KENJI
Japan Pharmaceutical Manufacturers Association
-
TANAKA YOSHITAKA
Japan Pharmaceutical Manufacturers Association
-
NAKAMURA SHOUHEI
Japan Pharmaceutical Manufacturers Association
-
HIRANO FUMIYA
Japan Pharmaceutical Manufacturers Association
-
HONBO TOSHIYASU
Japan Pharmaceutical Manufacturers Association
-
KADOTA TOSHIHITO
Japan Pharmaceutical Manufacturers Association
-
MATSUZAWA TOSHIAKI
Japan Pharmaceutical Manufacturers Association
-
Ando Kentaro
Japan Agency For Marine‐earth Sci. And Technol. Yokosuka Jpn
-
Kadota Toshihito
Japan Pharmaceutical Manufactures Association (jpma) Basic Research A1 Group Glp Requirement Subteam
-
Kadota Toshihito
Non-clinical Evaluation Subcommittee Drug Evaluation Japan Pharmaceutical Manufacturers Association
-
Nakamura Shouhei
Japan Pharmaceutical Manufactures Association (jpma) Basic Research A1 Group Glp Requirement Subteam
-
Matsuzawa Toshiaki
Non-clinical Evaluation Subcommittee Drug Evaluation Committee Japan Pharmaceutical Manufacturers As
-
Matsuzawa Toshiaki
Non-clinical Evaluation Subcommittee Drug Evaluation Japan Pharmaceutical Manufacturers Association
-
Kubota Kunitsugu
Japan Pharmaceutical Manufactures Association (jpma) Basic Research A1 Group Glp Requirement Subteam
-
Okayachi Hiroshi
Japan Pharmaceutical Manufactures Association (jpma) Basic Research A1 Group Glp Requirement Subteam
-
Matsuzawa Toshiaki
Non-clinical Evaluation Subcommittee Drug Evaluation Japan Pharmaceutical Manufacturers Association
関連論文
- P8-20 QT Interval Prolongation : Project for Database Construction, 14) Safety Margins of Drug-Induced QT Interval Prolongation: Comparison of Non-Clinical Animal Models and Clinical Data(CIRCULATORY SYSTEM-2/ACTIVE OXYGEN)(GENERAL SESSION BY POSTER PRESE
- Questionnaire survey of application in S7A Safety Pharmacology Guideline (Part 2) : Point of GLP (STATISTICAL METHODS) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)
- Questionnaire survey of application in S7A Safety Pharmacology Guideline (Part 1) : Point of experimental items (STATISTICAL METHODS) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)
- Survey of Carcinogenicity Studies of the Pharmaceuticals in Rodents
- A Comparision of the Results of Rat and Mouse Carcinogenicity Studies Conducted on Pharmaceuticals
- Questionnaire survey on cardiac electrophysiology examination in safety pharmacology studies.(GENERAL SESSION BY POSTER PRESENTATION)(SAFETY PHARMACOLOGY)
- P8-49 Questionnaire Survey of GLP Operation for S7A Safety Pharmacology Study in Japanese and Foreign CROs(BLOOD/TOXICOKINETICS/OTHERS-2)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting)
- QT PRODACT : Evaluation of the Potential of Compounds to Cause QT Interval Prolongation by Action Potential Assays Using Guinea-Pig Papillary Muscles
- QT PRODACT : A Multi-site Study of In Vitro Action Potential Assays on 21 Compounds in Isolated Guinea-Pig Papillary Muscles
- P8-19 QT Interval Prolongation : Project for Database Construction, 13) Species-Difference in Dose-Response Relationship of Drug-Induced QT Interval Prolongation(CIRCULATORY SYSTEM-2/ACTIVE OXYGEN)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of th
- P8-18 QT Interval Prolongation : Project for Database Construction, 12) QT prolongation: Comparison of the sensitivity between canine telemetry assay and isoflurane-anesthetized model(CIRCULATORY SYSTEM-2/ACTIVE OXYGEN)(GENERAL SESSION BY POSTER PRESENTAT
- P8-13 QT interval prolongation : Project for Database Construction, 7) Dose (concentration)-response analysis of drug-induced QT interval prolongation in conscious monkeys(CIRCULATORY SYSTEM-2/ACTIVE OXYGEN)(GENERAL SESSION BY POSTER PRESENTATION)(Proceed
- P8-10 QT Interval Prolongation : Project for Database Construction, 4) Inter-facility Differences in Electrocardiographic and Hemodynamic Parameters in Telemetered Monkeys(CIRCULATORY SYSTEM-2/ACTIVE OXYGEN)(GENERAL SESSION BY POSTER PRESENTATION)(Proceed
- P8-09 QT Interval Prolongation : Project for Database Construction, 3) Inter-facility Differences in Electrocardiograhic and Hemodynamic Parameters in Telemetered Dogs(CIRCULATORY SYSTEM-2/ACTIVE OXYGEN)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings
- O-09 No-Observed Adverse Effect Level(NOAEL) : Judging Criteria and Purpose in Safety Assessment of Pharmaceuticals(STATISTICAL AND TEST METHODS/GENERAL TOXICITY)(GENERAL SESSION BY ORAL PRESENTATION)(Proceedings of the 31st Annual Meeting)
- O-08 Questionnaire Survey on No Observed Adverse Effect Level(2) : Regulatory Comments and Company(STATISTICAL AND TEST METHODS/GENERAL TOXICITY)(GENERAL SESSION BY ORAL PRESENTATION)(Proceedings of the 31st Annual Meeting)
- O-07 Questionnaire Survey on No Observed Adverse Effect Level(1) : Concept of NOAEL(STATISTICAL AND TEST METHODS/GENERAL TOXICITY)(GENERAL SESSION BY ORAL PRESENTATION)(Proceedings of the 31st Annual Meeting)
- Survey of pharmacology study conduct using outside sources in pharmaceutical companies in Japan.(GENERAL SESSION BY ORAL PRESENTATION)(MINI SYMPOSIUM : CONSIDERATION OF OUTSOURCINGS AND MONITORING IN NON-CLINICAL STUDY(CURRENT SURVEY))
- Study Monitor : The Surveillance of Outsourced Non-Clinical Studies : Draft Report, Final Report, Archives, and Quality Assurance(GENERAL SESSION BY ORAL PRESENTATION)(MINI SYMPOSIUM : CONSIDERATION OF OUTSOURCINGS AND MONITORING IN NON-CLINICAL STUDY(CUR
- Study monitor : the Surveillance of Outsourced Non-Clinical Studies (Reproductive Studies,Pathology and Toxicokinetics).(GENERAL SESSION BY ORAL PRESENTATION)(MINI SYMPOSIUM : CONSIDERATION OF OUTSOURCINGS AND MONITORING IN NON-CLINICAL STUDY(CURRENT SURV
- Study Monitor. The Surveillance of Outsourced Non-Clinical Studies : Testing facility checking, Protocol, Formulation and In-life phase(GENERAL SESSION BY ORAL PRESENTATION)(MINI SYMPOSIUM : CONSIDERATION OF OUTSOURCINGS AND MONITORING IN NON-CLINICAL STU
- Study Monitor. Introduction of the Surveillance for Outsourcing Non-Clinical Studies and Summary of Toxicology.(GENERAL SESSION BY ORAL PRESENTATION)(MINI SYMPOSIUM : CONSIDERATION OF OUTSOURCINGS AND MONITORING IN NON-CLINICAL STUDY(CURRENT SURVEY))
- Point to Consider in Non-Clinical Studies on Each Category of Biotechnology-Derived Pharmaceuticals.(GENERAL SESSION BY ORAL PRESENTATION)(MINI SYMPOSIUM : CONSIDERATION OF NON-CLINICAL STUDIES ON BIO-PHARMACEUTICALS(CURENT SURVEY))
- P8-48 Questionnaire Survey about GLP Requirements for Safety Pharmacology(BLOOD/TOXICOKINETICS/OTHERS-2)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting)
- Pre-Japan-ARGO : Experimental Observation of Upper and Middle Layers South of the Kuroshio Extension Region Using Profiling Floats
- P8-21 QT Interval Prolongation : Project for Database Construction, 15) Relationship of pharmacokinetics and QT prolongation by various therapeutic agents: Telemetry study in dogs and monkeys(CIRCULATORY SYSTEM-2/ACTIVE OXYGEN)(GENERAL SESSION BY POSTER P
- Summary of Questionnaire Surveys of Toxicokinetics in Pharmaceutical Industries in Japan.(GENERAL SESSION BY ORAL PRESENTATION)(MINI SYMPOSIUM : STRATEGIC TOXICOKINETICS ON DRUG DISCOVERY(CURRENT SURVEY))
- Stability of Temperature and Conductivity Sensors of Argo Profiling Floats
- Responsibility of Monitor for Quality Assurance of Outsourcing Non-clinical Studies.(GENERAL SESSION BY ORAL PRESENTATION)(MINI SYMPOSIUM : CONSIDERATION OF OUTSOURCINGS AND MONITORING IN NON-CLINICAL STUDY(CURRENT SURVEY))
- Questionnaire survey of methodologies on respiration systems in safety pharmacological studies (TEST METHODS) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)
- Evaluation of cardiovascular safety pharmacology study using new data acquisition and real time data analyzing system (HEM).
- P11-13 Questionnaire Survey of Functional Observational Battery in Domestic and Foreign Non-clinical Contract Research Organization.
- O10-18 Questionnaire Survey of Functional Observational Battery in Domestic and Foreign Non-clinical Contract Research Organization.
- W4-4 QT Interval Prolongation : Project for Database Construction. 3) Overview of monkey telemetry studies(WORKSHOP 4: QT DATABASE CONSTRUCTION TO SUPPORT TO DEVELOP ICH-S7B GUIDELINE(SAFETY PHARMACOLOGY STUDIES TO EVALUATE QT INTERVAL PROLONGATION))(Proc
- Two Modes of Salinity and Temperature Variation in the Surface Layer of the Pacific Warm Pool
- In-situ Diurnal Sea Surface Temperature Variations and Near-Surface Thermal Structure in the Tropical Hot Event of the Indo-Pacific Warm Pool